HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Prando, A. Articles by Wallace, S. Search for Related Content PubMed PubMed Citation Articles by Prando, A. Articles by Wallace, S. Social Bookmarking                      What's this?

Helical CT of Prostate Cancer

Early Clinical Experience

¹ Radiological Center of Campinas, Av. Andrade Neves, 707, Campinas-S.P.-Brazil 13013-161.
² Department of Diagnostic Radiology, Box 57, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030.

OBJECTIVE. This study was undertaken to determine whether helical CT can reveal carcinoma of the prostate detected at transrectal sonographically guided biopsy.

MATERIALS AND METHODS. Helical CT of the prostate was performed in 35 patients: 25 with proven prostate cancer (group I) and 10 without cancer detected at biopsy (group II). All patients in group I had cancer in the peripheral zone, and three of these showed foci of cancer in the transitional zone. All patients of group II had undergone at least two sets of biopsy before CT. In group I, areas of contrast enhancement in the peripheral zone of the prostate were defined as suggestive of cancer and correlated with the histopathologic findings.

RESULTS. Helical CT revealed cancer in 22 (88%) of 25 patients with proven prostate cancer. Transrectal sonographically guided biopsy detected 102 cancer sites in the peripheral zone and three in the transitional zone in these 25 patients. Helical CT accurately revealed 59 peripheral zone cancer sites (58%) but did not reveal 43 cancer sites (42%). Abnormal contrast enhancement in the peripheral zone that was not caused by cancer was seen in 10% of suspicious lesions. The three cancer sites in the transitional zone were indistinguishable from benign nodular changes.

CONCLUSION. Prostate cancer detected at transrectal sonographically guided biopsy appears on helical CT of the prostate as focal or diffuse areas of contrast enhancement in the peripheral zone. A prospective study has been initiated to determine the accuracy, sensitivity, and specificity.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. Prando, J. Kurhanewicz, A. P. Borges, E. M. Oliveira Jr, and E. Figueiredo Prostatic Biopsy Directed with Endorectal MR Spectroscopic Imaging Findings in Patients with Elevated Prostate Specific Antigen Levels and Prior Negative Biopsy Findings: Early Experience Radiology, September 1, 2005; 236(3): 903 - 910. [Abstract] [Full Text] [PDF]

				M. R. Engelbrecht, H. J. Huisman, R. J. F. Laheij, G. J. Jager, G. J. L. H. van Leenders, C. A. Hulsbergen-Van De Kaa, J. J. M. C. H. de la Rosette, J. G. Blickman, and J. O. Barentsz Discrimination of Prostate Cancer from Normal Peripheral Zone and Central Gland Tissue by Using Dynamic Contrast-enhanced MR Imaging Radiology, October 1, 2003; 229(1): 248 - 254. [Abstract] [Full Text] [PDF]

				M. J. Haut, J. F. Harryhill, J. Rosenstock, M. J. Warhol, and R. Vitti Progressing Prostate Carcinoma Oncologist, April 1, 2001; 6(2): 183 - 196. [Abstract] [Full Text]